AKT1 and breast cancer: The Akt pathway has been found to be activated in early stages of breast cancer development [58], and activation of Akt signaling protects breast cancer cells from tamoxifen-induced apoptosis in vitro and confers poor prognosis in cancer patients [59, 60].